Max Healthcare reports net loss of Rs 355 crore in Q1
New Delhi: Max Healthcare on Tuesday reported a loss of Rs 355 crore for the first quarter ended June 30, mainly on account of the COVID-19 pandemic.The company had posted a net profit of Rs 9 crore in the corresponding period previous fiscal, Max Healthcare said in a regulatory filing.The gross revenue of the company stood at Rs 610 crore during the quarter under consideration as against...
Login or Register to read the full article
New Delhi: Max Healthcare on Tuesday reported a loss of Rs 355 crore for the first quarter ended June 30, mainly on account of the COVID-19 pandemic.
The company had posted a net profit of Rs 9 crore in the corresponding period previous fiscal, Max Healthcare said in a regulatory filing.
The gross revenue of the company stood at Rs 610 crore during the quarter under consideration as against Rs 1,059 crore in the same period a year ago, it added.
"... these have been exciting times for the Max Healthcare starting with the merger of Radiant Life Care Pvt Ltd with Max Healthcare, followed by its listing and a new corporate brand identity that reflects the company's strategic vision, values, and purpose of the new organisation i.e. 'To Serve, To Excel'," Max Healthcare Institute Chairman and MD Abhay Soi said.
The company intends to continue its efforts towards structural realignment, bring digital to the core, realise synergies, and continue to walk on a growth trajectory, he added.
The company also said its board has approved the proposal for issuance of equity shares of the face value of Rs 10 each and/ or other eligible securities by the company by way of qualified institutions placement (QIP) for an issue size aggregating up to Rs 1,200 crore.
The board has also cleared "private placement of non-convertible debentures for an amount up to 550 crore, in one or more tranches, during a period of one year from the shareholders' approval at the 19th AGM of the company," it added.
Shares of Max Healthcare Institute settled at Rs 107.55 apiece on BSE, up 0.51 percent from its previous close.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd